NCT00333294View on ClinicalTrials.gov

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

January 31, 2006

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

Gefitinib

PROCEDURE

Radiation therapy

DRUG

Cisplatin

DRUG

Vinorelbine

Trial Locations (4)

Unknown

Research Site, Clermont-Ferrand

Research Site, Grenoble

Research Site, Nantes

Research SIte, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY